Management of Heart Failure, Durable Left Ventricular Assist Device, and Heart Transplant Patients in the COVID-19 Era
By: Nadia Fida
References
- Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 May 12;75(18):2352–2371. doi: 10.1016/j.jacc.2020.03.031
- Sandoval Y, Januzzi JL
Jr , Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Sep 8;76(10):1244–1258. doi: 10.1016/j.jacc.2020.06.068 - Lala A, Johnson KW, Januzzi JL, et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020 Aug 4;76(5):533–546. doi: 10.1016/j.jacc.2020.06.007
- Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020 Mar;63(3):364–374. doi: 10.1007/s11427-020-1643-8
- Das M, Bristow MR, Chung MK. The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2. JACC Basic Transl Sci. 2021 Apr 27;6(4):346–349. doi: 10.1016/j.jacbts.2021.02.010
- Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020 May 14;41(19):1861–1862. doi: 10.1093/eurheartj/ehaa286
- Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020 May;45(3):230–232. doi: 10.1007/s00059-020-04909-z
- Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020 May;22(5):911–915. doi: 10.1002/ejhf.1828
- Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802–810. doi: 10.1001/jamacardio.2020.0950
- Bailey AL, Dymtrenko O, Greenberg L, et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis. JACC Basic Transl Sci. 2021 Apr;6(4):331–345. doi: 10.1016/j.jacbts.2021.01.002
- Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811–818. doi: 10.1001/jamacardio.2020.1017
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3
- Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26;368:
m1091 . doi: 10.1136/bmj.m1091 - Fried JA, Ramasubbu K, Bhatt R, et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation. 2020 Jun 9;141(23):1930–1936. doi: 10.1161/CIRCULATIONAHA.120.047164
- Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708–1720. doi: 10.1056/NEJMoa2002032
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475–481. doi: 10.1016/S2213-2600(20)30079-5
- WHO.int [Internet]. Geneva, Switzerland: World Health Organization; c2021. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected; 2020 Jan 28 [cited 2021 Oct 15]. Available from:
https://www.who.int/publications/i/item/10665-332299 - Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061–1069. doi: 10.1001/jama.2020.1585
- Santoro F, Monitollo F, Raimondo P, et al. QTc Interval Prolongation and Life-Threatening Arrhythmias During Hospitalization in Patients With Coronavirus Disease 2019 (COVID-19): Results From a Multicenter Prospective Registry. Clin Infect Dis. 2020 Oct 24;
ciaa1578 . doi: 10.1093/cid/ciaa1578 - Zhang Y, Coats AJS, Zheng Z, et al. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Jun;22(6):941–956. doi: 10.1002/ejhf.1915
- Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020 May;17(5):533–535. doi: 10.1038/s41423-020-0402-2
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
- Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):819–824. doi: 10.1001/jamacardio.2020.1096
- Raja MA, Mendoza MA, Villavicencio A, et al. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. Transplant Rev (Orlando). 2021 Jan;35(1):
100588 . doi: 10.1016/j.trre.2020.100588 - Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020 Jun 18;382(25):2431–2440. doi: 10.1056/NEJMoa2006923
- Baral R, Tsampasian V, Debski M, et al. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021 Mar 1;4(3):
e213594 . doi: 10.1001/jamanetworkopen.2021.3594 - Lopes RD, Macedo AVS, de Barros E Silva PGM, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jan 19;325(3):254–264. doi: 10.1001/jama.2020.25864
- Clemente-Moragón A, Martínez-Milla J, Oliver E, et al. J Am Coll Cardiol. 2021 Sep 7;78(10):1001–1011. doi: 10.1016/j.jacc.2021.07.003
- Badulak J, Antonini MV, Stead CM, et al. Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J. 2021 May 1;67(5):485–495. doi: 10.1097/MAT.0000000000001422
- Talasaz AH, Rashidi F, Sharif-Kashani, et al.; INSPIRATION Investigators. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 Apr 27;325(16):1620–1630. doi: 10.1001/jama.2021.4152
- Lopes RD, de Barros e Silva PGM, Furtado RHM, et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021 Jun 12;397(10291):2253–2263. doi: 10.1016/S0140-6736(21)01203-4
- REMAP-CAP Investigators, ACTIV-4a Investigators, ATTACC Investigators, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. New Engl J Med. 2021 Aug 26;385(9):777–789. doi: 10.1056/NEJMoa2103417
- Birati EY, Najjar SS, Tedford RJ, et al. Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support. Circ Heart Fail. 2021 Apr;14(4):
e007957 . doi: 10.1161/CIRCHEARTFAILURE.120.007957 - Coll E, Fernández-Ruiz M, Padilla M, et al. COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave? Transplantation. 2021 Oct 1;105(10):2146–2155. doi: 10.1097/TP.0000000000003873
- Bottio T, Bagozzi L, Fiocco A, et al. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak. JACC Heart Fail. 2021 Jan;9(1):52–61. doi: 10.1016/j.jchf.2020.10.009
- Latif F, Farr MA, Clerkin KJ, et al. Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019. JAMA Cardiol. 2020 Oct 1;5(10):1165–1169. doi: 10.1001/jamacardio.2020.2159
- Genuardi MV, Moss N, Najjar SS, et al. Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes. J Heart Lung Transplant. 2021 Sep;40(9):926–935. doi: 10.1016/j.healun.2021.05.006
- Ishlt.org [Internet]. Addison, TX: International Society for Heart and Lung Transplantation; c2021.
Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic ; 2021 February 1 [cited 2021 Nov 11]. Available from:https://ishlt.org/ishlt/media/documents/SARS-CoV-2_Guidance-for-Cardiothoracic-Transplant-and-VAD-center.pdf - Ishlt.org [Internet]. Addison, TX: International Society for Heart and Lung Transplantation, American Society of Transplantation; c2021.
Joint Statement about Vaccine Efficacy in Organ Transplant Recipients . 2021 Aug 13 [cited 2021 Nov 11]. Available from:https://ishlt.org/ishlt/media/documents/ISHLT-AST_SARS-CoV-2-Vaccination_8-13-21.pdf - Ishlt.org [Internet]. Addison, TX: International Society for Heart and Lung Transplantation; c2021.
SARS-CoV-2 Vaccination in Heart and Lung Transplantation, MCS and PH ; 2021 May 21 [cited 2021 Oct 15]. Available from:https://ishlt.org/ishlt/media/documents/COVID19_Vaccine-Recommendations_5-21-2021.pdf - Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021 Apr 15;384(15):1412–1423. doi: 10.1056/NEJMoa2101765
- Vasileiou E, Simpson CR, Shi T, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021 May 1;397(10285):1646–1657. doi: 10.1016/S0140-6736(21)00677-2
- MedRxiv.org [Internet]. Pritchard E, Matthews PC, Stoesser N, et al. Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey; 2021 Apr 23 [cited 2021 Oct 15]. Available from:
https://www.medrxiv.org/content/10.1101/2021.04.22.21255913v1 - Malinis M, Cohen E, Azar MM. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients. Am J Transplant. 2021 Aug;21(8):2916–2918. doi: 10.1111/ajt.16713
- Qin CX, Moore LW, Anjan S, et al. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients. Transplantation. 2021 Nov 1;105(11):e265–e266. doi: 10.1097/TP.0000000000003907
DOI: https://doi.org/10.14797/mdcvj.651 | Journal eISSN: 1947-6108
Language: English
Page range: 63 - 72
Submitted on: Aug 31, 2021
Accepted on: Nov 11, 2021
Published on: Dec 15, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2021 Nadia Fida, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.